Home
>
National Drug Code (NDC)
>
Sandostatin
Sandostatin - 0078-0183-25 - (octreotide acetate)
Drug Information of Sandostatin
| Product NDC: | 0078-0183 |
| Proprietary Name: | Sandostatin |
| Non Proprietary Name: | octreotide acetate |
| Active Ingredient(s): | 200 ug/mL & nbsp; octreotide acetate |
| Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Sandostatin
| Product NDC: | 0078-0183 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019667 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19981021 |
Package Information of Sandostatin
| Package NDC: | 0078-0183-25 |
| Package Description: | 1 VIAL, MULTI-DOSE in 1 BOX (0078-0183-25) > 5 mL in 1 VIAL, MULTI-DOSE |
NDC Information of Sandostatin
| NDC Code | 0078-0183-25 |
| Proprietary Name | Sandostatin |
| Package Description | 1 VIAL, MULTI-DOSE in 1 BOX (0078-0183-25) > 5 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 0078-0183 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | octreotide acetate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 19981021 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | OCTREOTIDE ACETATE |
| Strength Number | 200 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] |
